Immuneering Corporation (IMRX)
1.94
-0.01 (-0.51%)
At close: Jan 15, 2025, 2:32 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -3.91 | -2.6 | -12.69 | -26.34 | -55.68 |
| PS Ratio | n/a | 403.77 | 204.62 | 194.16 | 233.78 |
| PB Ratio | 2.31 | 1.17 | 2.73 | -19.96 | -68.76 |
| P/FCF Ratio | -4.24 | -2.85 | -13.77 | -30.58 | -100.56 |
| P/OCF Ratio | -4.27 | -2.9 | -13.8 | -30.7 | -101.02 |
| OCF/S Ratio | n/a | -139.14 | -14.83 | -6.33 | -2.31 |
| Debt / Equity Ratio | 0.05 | 0.04 | 0.03 | -0.03 | -2.55 |
| Quick Ratio | 11.35 | 13.50 | 27.04 | 16.73 | 27.83 |
| Current Ratio | 11.35 | 13.50 | 27.04 | 16.73 | 27.83 |
| Asset Turnover | n/a | 0.00 | 0.01 | 0.06 | 0.14 |
| Interest Coverage | n/a | -51.01 | n/a | n/a | -17.91 |
| Return on Equity (ROE) | -0.59 | -0.45 | -0.22 | 0.76 | 1.24 |
| Return on Assets (ROA) | -0.52 | -0.4 | -0.2 | -0.44 | -0.57 |
| Return on Capital (ROIC) | -0.62 | -0.45 | -0.21 | -0.47 | -0.46 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 50.11% | 44.56% | 44.61% | 36.29% |
| Net Profit Margin | n/a | -15.55K% | -1.61K% | -737.17% | -419.89% |
| Pretax Profit Margin | n/a | -15.94K% | -1.63K% | -737.17% | -401.59% |
| Operating Profit Margin | n/a | -16.33K% | -1.63K% | -739.01% | -327.71% |
| FCF Margin | n/a | -14.15K% | -1.49K% | -634.83% | -232.48% |
| EBITDA Margin | n/a | -16.24K% | -1.62K% | -735.58% | -382.35% |